Clinical Trial

Quality of Life in Presbyopic Patients Who Are Treated With Qlosi

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to determine how Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%impacts the quality of life of participants with presbyopia by using a battery of validated and investigator-developed instruments * Improvement in presbyopic symptoms as measured with the Near Activity Visual Questionnaire-Presbyopia (NAVQ-P) when using Qlosi™ at week 4 compared to baseline (continuous variable). * Improvement in presbyopic symptoms as measured with the Visual Quality of Life with Time Survey (VisQualT) questionnaire when using Qlosi™ at week 4 compared to baseline.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-02.
Trial Details
NCT Number NCT07113210
Lead Sponsor Southern College of Optometry
Conditions Presbyopia, Glasses, Dry Eye
Enrollment 36 participants
Start Date 2025-07-18
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-12